Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study To Validate Key Therapeutic Targets and Characterise Their Response to Corticosteroids in Multiple Asthma Phenotypes

NCT00331058 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00331058
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00331058 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study To Validate Key Therapeutic Targets and Characterise Their Response to Corticosteroids in Multiple Asthma Phenotypes
Lead sponsor
GlaxoSmithKline
Phase
Phase 1
Overall status
Terminated
Start date
February 18, 2006
Completion date
July 7, 2011
Enrollment
58 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

asthma